Fairchem Organics
Fairchem Organics (FAIRCHEMOR) share price was ₹677.25 at the 28 Oct 2026 close; market capitalisation ₹853 Cr; P/E (TTM) 35.89; sector Chemicals. The share price fell 9.8% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Sep 2026 quarter, revenue rose 49.7% year on year to ₹166.9 Cr and net profit was ₹10 Cr, against ₹1 Cr a year earlier (compared with Sep 2025). Promoters held 63.26% of Fairchem Organics in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 48/100 (Average) as of 28 Oct 2026.
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of 28 Oct 2026, 15:31 IST · EPS basis: Standalone · TTM
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,389.60 | 53.41 | 1,41,445 Cr | 13.07 | 1.48% | 22.36% | 28.48% | 15,689 Cr | 2,677 Cr | |
| ₹4,267.10 | 77.47 | 46,874 Cr | 6.00 | 0.07% | 7.25% | 10.13% | 5,334 Cr | 600 Cr | |
| ₹8,501.00 | 55.18 | 43,604 Cr | 10.98 | 0.18% | 16.70% | 18.66% | 3,734 Cr | 789 Cr | |
| ₹1,588.40 | 89.59 | 21,082 Cr | 8.58 | 0.00% | 8.94% | 12.15% | 1,257 Cr | 235 Cr | |
| ₹1,488.40 | 25.92 | 20,301 Cr | 3.48 | 0.52% | 9.38% | 10.85% | 8,624 Cr | 784 Cr | |
| ₹437.30 | 29.87 | 15,856 Cr | 2.66 | 0.23% | 7.04% | 8.53% | 9,040 Cr | 531 Cr | |
| ₹5,225.50 | 19.93 | 15,385 Cr | 2.34 | 0.55% | 10.95% | 13.54% | 7,185 Cr | 788 Cr | |
| Fairchem Organics (this company) | ₹677.25 | 35.89 | 853 Cr | 3.03 | 0.14% | 2.11% | 3.84% | 562 Cr | 24 Cr |
| Median 8 companies | ₹1,538.40 | 44.65 | 20,692 Cr | 4.74 | 0.21% | 9.16% | 11.50% | 6,260 Cr | 692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
v2.0.0
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is expected to give good quarter
Weaknesses
4- Stock is trading at 3.41 times its book value
- The company has delivered a poor sales growth of 3.00% over past five years.
- Company has a low return on equity of 8.07% over last 3 years.
- Company might be capitalizing the interest cost
Technical Indicators
Oscillators
Neutral
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 10% · Sep 2026
Quarterly Results
| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 152 | 148 | 161 | 165 | 139 | 114 | 121 | 131 | 112 | 100 | 117 | 176 | 167 |
| Expenses | 135 | 128 | 142 | 143 | 130 | 106 | 116 | 126 | 107 | 96 | 109 | 158 | 149 |
| Operating Profit | 17 | 20 | 19 | 22 | 9 | 8 | 4 | 5 | 4 | 4 | 8 | 18 | 18 |
| OPM % | 11% | 13% | 12% | 13% | 6% | 7% | 3.7% | 4% | 3.8% | 4.2% | 7% | 10% | 10% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Depreciation | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| PBT | 14 | 17 | 16 | 19 | 5 | 5 | 1 | 2 | 1 | 0 | 5 | 14 | 14 |
| Tax % | 26% | 26% | 26% | 26% | 27% | 25% | 47% | 27% | 35% | -48% | 22% | 27% | 26% |
| Net Profit | 10 | 12 | 12 | 14 | 4 | 4 | 1 | 1 | 1 | 0 | 4 | 10 | 10 |
| EPS (₹) | 7.9 | 9.47 | 9.03 | 10.64 | 3.08 | 2.7 | 0.45 | 0.9 | 0.59 | -0.08 | 2.93 | 7.95 | 8.07 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 306 | 397 | 643 | 648 | 621 | 538 | 460 | 560 |
| Expenses | 258 | 328 | 538 | 576 | 554 | 495 | 438 | 513 |
| Operating Profit | 49 | 69 | 105 | 72 | 67 | 43 | 22 | 48 |
| OPM % | 16% | 17% | 16% | 11% | 11% | 8% | 4.7% | 8% |
| Other Income | 6 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
| Interest | 7 | 7 | 7 | 6 | 4 | 4 | 4 | 5 |
| Depreciation | 6 | 7 | 7 | 8 | 9 | 11 | 11 | 11 |
| PBT | 42 | 56 | 91 | 59 | 55 | 30 | 7 | 32 |
| Tax % | 18% | 24% | 26% | 26% | 26% | 27% | 24% | — |
| Net Profit | 35 | 42 | 68 | 44 | 40 | 22 | 6 | 24 |
| EPS (₹) | — | 32.62 | 52.15 | 33.41 | 31.1 | 16.87 | 4.4 | 18.87 |
| Div. Payout % | 0% | 11% | 25% | 22% | 24% | 44% | 0% | — |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 127 | 156 | 219 | 246 | 277 | 289 | 250 | 269 |
| Borrowings | 67 | 57 | 62 | 50 | 7 | 63 | 84 | 70 |
| Other Liabilities | 25 | 33 | 30 | 33 | 37 | 37 | 44 | 46 |
| Total Liabilities | 219 | 259 | 324 | 342 | 334 | 402 | 391 | 398 |
| Fixed Assets | 126 | 126 | 141 | 156 | 191 | 201 | 196 | 207 |
| CWIP | 9 | 29 | 42 | 35 | 6 | 12 | 18 | 8 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 83 | 103 | 141 | 151 | 137 | 189 | 176 | 183 |
| Total Assets | 219 | 259 | 324 | 342 | 334 | 402 | 391 | 398 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 31 | 40 | 40 | 50 | 74 | -17 | 42 |
| Investing | -24 | -23 | -34 | -14 | -18 | -26 | -14 |
| Financing | -7 | -17 | -6 | -35 | -57 | 42 | -28 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 1 | 17 | 6 | 35 | 57 | -42 | 28 |
| CFO/EBITDA | 82 | 77 | 60 | 88 | 131 | -15 | 180 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 45 | 43 | 35 | 35 | 33 | 58 | 54 |
| Inventory Days | 65 | 64 | 57 | 61 | 57 | 87 | 96 |
| Days Payable | 12 | 15 | 7 | 8 | 11 | 8 | 12 |
| Cash Conversion Cycle | 98 | 91 | 85 | 89 | 80 | 137 | 139 |
| Working Capital Days | 14 | 43 | 40 | 46 | 63 | 68 | 53 |
| ROCE % | — | 30% | 38% | 22% | 19% | 10% | 3% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Fairchem Organics insights
65 extracted metrics + investor summaries across FY12–FY27.
Documents
Frequently Asked Questions about Fairchem Organics
What does Fairchem Organics Ltd do?
Where is Fairchem Organics Ltd (FAIRCHEMOR) listed?
Which sector does Fairchem Organics Ltd belong to?
What is the market capitalisation of Fairchem Organics Ltd?
What is the PE ratio of Fairchem Organics Ltd?
What is the 52-week high and low of Fairchem Organics Ltd?
Does Fairchem Organics Ltd pay dividends?
What is the Return on Equity (ROE) of Fairchem Organics Ltd?
Company Information
Fairchem Organics Limited was established in 2019, wherein Fairchem Speciality Limited (FSL) transferred the businesses of Oleo chemicals and nutraceuticals as per the scheme of demerger. Fairchem Organics is engaged in manufacturing of specialty chemicals like dimer acid, linoleic acid, mixed tocopherol concentrate and sterols concentrate, which find application in various industries like nutraceuticals, paints, printing ink, detergents, adhesives, etc.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/FAIRCHEMOR.md for Fairchem Organics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.